Product Information
CALCIPOTRIENE 0.005% OINTMENT is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $2.3377 per GM under NDC 68462031066. Its NADAC has been published 392 times since Apr 3, 2019.
FDA first approved this application on Mar 24, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 ug/g
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462031066
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
CALCIPOTRIENEApproval Type
Generic (ANDA)
FDA Application
ANDA090633FDA Approved
3/24/2010
TE Code
AB
On Market Since
3/24/2010
Pharmacological Classes
Price Statistics
The NADAC for CALCIPOTRIENE 0.005% OINTMENT has been published 392 times since Apr 3, 2019, and over the history we have for it it has risen 6.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.3377 per GM |
|---|---|
| All-time high | $2.7823 (Nov 16, 2022) |
| All-time low | $1.5937 (Apr 20, 2022) |
| 52-week high | $2.3377 |
| 52-week low | $1.8880 |
| Median price | $2.1199 |
| Average price | $2.1590 |
| Largest weekly change | +51.7% (Aug 17, 2022) |
| Weeks tracked | 392 |
| Tracking since | Apr 3, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Calcipotriene market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Vitamin D Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CALCIPOTRIENE 0.005% OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for CALCIPOTRIENE 0.005% OINTMENT, manufactured by Glenmark Pharmaceuticals Inc., USA, is $2.3377 per GM (NDC 68462031066), effective Sep 30, 2026.
How has the price of CALCIPOTRIENE 0.005% OINTMENT changed over time?
Over the history we have for it, the NADAC for CALCIPOTRIENE 0.005% OINTMENT has risen 6.6%. It has been tracked across 392 weekly CMS publications since Apr 3, 2019.
What are the highest and lowest recorded NADAC prices for CALCIPOTRIENE 0.005% OINTMENT?
Since Apr 3, 2019, the NADAC for CALCIPOTRIENE 0.005% OINTMENT has ranged from a low of $1.5937 (Apr 20, 2022) to a high of $2.7823 (Nov 16, 2022), with a median of $2.1199 per GM.
Are there cheaper alternatives to CALCIPOTRIENE 0.005% OINTMENT?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CALCIPOTRIENE 0.005% OINTMENT, is $2.0844 per GM — about 11% below CALCIPOTRIENE 0.005% OINTMENT.
Who manufactures CALCIPOTRIENE 0.005% OINTMENT?
CALCIPOTRIENE 0.005% OINTMENT (NDC 68462031066) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.